Related Experiment Video

Updated: Oct 4, 2025

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

3.2K

Significant impact of mTORC1 and ATF4 pathways in CHO cell recombinant protein production induced by CDK4/6 inhibitor

Meiping Chang1, Steven Huhn1, Luke Nelson1

  • 1Process Cell Sciences, Biologics Process R&D, Merck & Co., Inc., Kenilworth, New Jersey, USA.

Biotechnology and Bioengineering
|February 3, 2022
PubMed

Insights

CDK4/6 inhibitors boost protein production in CHO cells by activating mTORC1 signaling. This study elucidates the molecular mechanisms, including enhanced translation and stress responses, linking cell-cycle inhibition to increased productivity.

Area of Science:

  • Biotechnology
  • Cell Biology
  • Proteomics

Background:

  • Cyclin-dependent kinase (CDK) 4/6 inhibitors are known to enhance recombinant protein productivity in Chinese hamster ovary (CHO) cells.
  • The precise molecular mechanisms underlying this productivity enhancement remain incompletely understood.

Purpose of the Study:

  • To investigate the signaling pathways connecting cell-cycle inhibitor (CCI) treatment with increased protein productivity in CHO cells.
  • To identify key molecular events and signaling nodes involved in CCI-mediated productivity enhancement.

Main Methods:

  • Utilized comprehensive proteomics and phosphoproteomics to analyze protein changes and phosphorylation events in CCI-treated CHO cells.
  • Focused on identifying early signaling events and downstream effectors.

Main Results:

  • Identified mTORC1 as a critical early signaling event preceding boosted protein productivity.
  • Observed transient phosphorylation of mTOR at a novel, conserved site following CCI treatment.
  • Uncovered upstream links (AKT1S1, RB1) and downstream effects (EIF4EBP1, RPS6, tRNA-aminoacylation) on translation and protein synthesis.
  • Detected a persistent stress response (GCN2/EIF2AK4-ATF4 axis) potentially linking mTOR to protein folding and secretion pathways (UPR, autophagy).

Conclusions:

  • CDK4/6 inhibition triggers a complex network of signaling events in CHO cells, centered around mTORC1 activation.
  • These events collectively enhance the translational machinery and cellular capacity for protein production, folding, and secretion.
  • Provides a detailed molecular understanding of how cell-cycle inhibition improves biopharmaceutical manufacturing processes.
Keywords:
Chinese hamster ovarycell signalingmammalian biotechnologyphosphoproteomicsproteomics

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

317
Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes15:43

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes

Published on: January 7, 2013

18.3K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.7K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.9K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K